ロード中...

Development of the PGx‐Passport: A Panel of Actionable Germline Genetic Variants for Pre‐Emptive Pharmacogenetic Testing

Pre‐emptive pharmacogenetics (PGx) testing of a panel of germline genetic variants represents a new model for personalized medicine. Clinical impact of PGx testing is maximized when all variant alleles for which actionable clinical guidelines are available are included in the test panel. However, no...

詳細記述

保存先:
書誌詳細
出版年:Clin Pharmacol Ther
主要な著者: van der Wouden, Cathelijne H., van Rhenen, Mandy H., Jama, Wafa O.M., Ingelman‐Sundberg, Magnus, Lauschke, Volker M., Konta, Lidija, Schwab, Matthias, Swen, Jesse J., Guchelaar, Henk‐Jan
フォーマット: Artigo
言語:Inglês
出版事項: John Wiley and Sons Inc. 2019
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6771671/
https://ncbi.nlm.nih.gov/pubmed/31038729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.1489
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!